Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.
Manufactured by
HANGZHOU LAIHE BIOTECH CO.,LTD
China
Founded in 2012, Hangzhou Laihe Biotech Co., Ltd., has always focused on the development and industrialization of POCT instant diagnosis, monitoring and health information technology field, and is committed to providing fast, accurate and reliable health detection products and services to the public.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shandong Kanghua Biotechnology Co.,Ltd.
China · 4 relevant products
Beijing Leadman Biochemistry Co., Ltd
China · 1 relevant product
Xiamen Boson Biotech Co., Ltd
China · 1 relevant product
71 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 36 relevant matches
Shenzhen Xilaiheng Medical Electronics Co., Ltd · China
IVD kit for detection and quantification of troponin and other cardiac markers. Used for diagnosis and monitoring of myocardial infarction in acute care settings.
AEHEALTH Limited · China
Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.
Hangzhou Biotest Biotech Co., Ltd · China
A rapid immunochromatographic assay using colloidal gold-labeled fixed-phase technology to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, or plasma. The triple simultaneous detection provides greater clinical diagnostic significance for cardiac assessment.
33 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products